Extranodal NK-T-cell lymphoma epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
* Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America. | * Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America. | ||
* Nk cell lymphoma is usually associated with Epstein-Barr virus infection. | * Nk cell lymphoma is usually associated with Epstein-Barr virus infection. | ||
*NK T cell lymphoma, nasal type consist 3-10% of non-Hodgkin lymphoma in Asia and South America and less than 1% in Western countries.<ref name="pmid22393989">{{cite journal| author=Liu J, Song B, Fan T, Huang C, Xie C, Li J et al.| title=Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China. | journal=Asian Pac J Cancer Prev | year= 2011 | volume= 12 | issue= 11 | pages= 3055-61 | pmid=22393989 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22393989 }} </ref> | |||
=== Mortality rate === | === Mortality rate === | ||
* NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis. | * NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis. | ||
== References == | == References == | ||
<references /> | <references /> |
Revision as of 16:10, 19 August 2019
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics |
FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics |
CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics |
Extranodal NK-T-cell lymphoma epidemiology and demographics in the news |
Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2] Sowminya Arikapudi, M.B,B.S. [3]
Overview
Epidemiology and Demographics
Incidence
- Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
- Nk cell lymphoma is usually associated with Epstein-Barr virus infection.
- NK T cell lymphoma, nasal type consist 3-10% of non-Hodgkin lymphoma in Asia and South America and less than 1% in Western countries.[1]
Mortality rate
- NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.
References
- ↑ Liu J, Song B, Fan T, Huang C, Xie C, Li J; et al. (2011). "Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China". Asian Pac J Cancer Prev. 12 (11): 3055–61. PMID 22393989.